Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Bristol-Myers Squibb (NY: BMY )

50.10 +0.72 (+1.46%)
Official Closing Price Updated: 7:00 PM EST, Dec 1, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Bristol-Myers Squibb

< Previous 1 2
...
28 29 30 31 32 33 34 35 36
...
46 47 Next >
Groundbreaking Clinical Trials Accelerating New Treatment Options for Pancreatic Cancer
Palm Beach, FL – February 2, 2022 – FinancialNewsMedia.com News Commentary – In the battle against pancreatic cancer, new and innovative clinical trials have become extremely critical. These trials... 
Via FinancialNewsMedia
5 Things To Expect This Week
While the "January effect" was rather disappointing, February kicks off with an important week ahead for many types of investors. 
Via InvestorPlace
EMA's Advisory Committee Recommends Approval Of Bristol-Myers' Breyanzi In Lymphoma
The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP)  
Via Benzinga
Small Cap Biotech Stocks: Is it time to start trading?
It’s time to trade beaten-up small cap biotech stocks. 
Via Talk Markets
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
The Week Ahead In Biotech (Jan 31-Feb 5): Merck, Bristol-Myers Squibb, Lilly & Novartis Headline Large-Cap Biopharma Earnings News
The broader market weakness pervaded into the biotech sector in the week ending Jan. 28, sending stocks lower. 
Via Benzinga
Weekly Market Overview - Saturday, Jan. 29
Last week was a turbulent one for the stock market, with the S&P 500 declining about 100 points, or about 1.9% as of Thursday’s close. That might not sound like a lot, but the VIX reached its highest... 
Via Talk Markets
Top Picks 2022: Bristol-Myers Squibb (BMY)
Bristol-Myers Squibb is one of the world’s largest pharmaceutical companies. It manufactures cardiovascular and anti-cancer therapeutics, with annual revenues of about $42 billion. 
Via Talk Markets
Bristol Myers Squibb Receives Positive CHMP Opinion for CAR T Cell Therapy Breyanzi (lisocabtagene maraleucel) for Relapsed or Refractory DLBCL, PMBCL and FL3B
From Bristol Myers Squibb
Via Business Wire
Say Hello to 2022’s Dogs of the Dow: 10 Dividend Stocks to Watch
As investor appetite for high-growth stocks begins to decrease in the new year, dividend stocks will likely to gain traction in 2022. 
Via InvestorPlace
Hoth's Management Team And Scientific Advisory Board Report Wrapping Up A Busy 2021 Of Clinical Research
Image provided by Pixabay This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. 
Via Benzinga
R&D Spending Increases Exponentially for Higher Standard of Breast Cancer Drug Treatments
Palm Beach, FL – January 27, 2022 – FinancialNewsMedia.com News Commentary – According to International Agency for Research on Cancer (IARC) published by the World Health Organization (WHO) in 2018,... 
Via FinancialNewsMedia
Topics Death Intellectual Property
Exposures Death Intellectual Property
The Daily Biotech Pulse: Gilead's Blood Cancer Studies Placed On Partial Clinical Hold, Immunocore Gets FDA Nod, NRx Touts Positive COVID-19 Data
Here's a roundup of top developments in the biotech space over the last 24 hours. 
Via Benzinga
14 Stocks in the Healthcare Sector
Here are 14 companies in the Healthcare Sector that have investment-grade credit ratings of BBB- or better, cash flow yield of 6% or better, future total return of at least 5%. 
Via Talk Markets
3 Blue Chip Stocks Growing Their Earnings And Dividends
In times of elevated stock market volatility, investors should consider quality blue chip stocks like BMY, LYB, and VZ. 
Via Talk Markets
3 Healthcare Stocks Ignoring the Market Mayhem
Sellers dominate the Street this week, but some healthcare stocks remain unaffected. Here are three to put atop your watchlist. 
Via InvestorPlace
3 Pharma Stocks Yielding Over 3%
The Pharma industry faced headwinds in 2021 as hospitals delayed procedures and elective surgeries. 
Via Talk Markets
More Serious Matters
Wall Street fell on new worries about inflation and a drop in retail sales levels. 
Via Talk Markets
Looking Into Bristol-myers Squibb Company's Recent Short Interest
Bristol-myers Squibb Company's (NYSE:BMY) short percent of float has fallen 5.71% since last its last report. The company recently reported that it has 21.93 million shares sold... 
Via Benzinga
This Company Believes Physics, Not Chemistry, Is the Best Way To Develop Successful Protein Therapeutics
Picture credit: Michael Longmire on Unsplash This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing... 
Via Benzinga
The Daily Biotech Pulse: Adagio's Antibody Effective Against Omicron, Sarepta Terminates Gene Therapy Deal, AstraZeneca Inks Oncology Pact
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Adagio Says Lead Monoclonal Antibody Effective Against Omicron Variant Adagio... 
Via Benzinga
Interest Rate Hikes And Stocks
Abnormal flooding in northwest Brazil has blocked iron ore mining which resulted in a jump in the price of ore. 
Via Talk Markets
Bristol Myers, 2seventy Pull Plug On Multiple Myeloma CAR-T As Abecma Sales Gain Momentum
2seventy bio Inc's (NASDAQ: TSVT) anti-BCMA CAR-T got axed as part of a corporate update. The treatment was under development in collaboration with Bristol... 
Via Benzinga
The Daily Biotech Pulse: Illunina Announces Multiple Partnerships, Immunome Slides On Regulatory Setback For COVID Antibody Drug, Preannouncements Pour In
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus BioAtla, Bristol-Myers Squibb Announce Collaboration To Evaluate ADC-Opdivo... 
Via Benzinga
Start Of The Week
British property (real estate) stocks fell today. 
Via Talk Markets
3 Top Stock Trades for the Week of Jan. 10, 2022
Sellers continue to push their advantage making it necessary to play defense to win. Here are three top stock trades for the new week. 
Via InvestorPlace
Bristol Myers Squibb Shares Jump After J.P. Morgan Healthcare Conference Presentation
Bristol Myers Squibb Co (NYSE: BMY) kicked off the Big Pharma presentations at the J.P. Morgan healthcare conference. The execs said the drugmaker aims to grow despite... 
Via Benzinga
Why Bristol-Myers Squibb Shares Are Trading Higher Today
Bristol-Myers Squibb Co (NYSE: BMY) is trading higher Monday after the company announced a $5 billion buyback and issued FY22 financial guidance. Bristol-Myers said it... 
Via Benzinga
Bristol Myers, Century Therapeutics Ink Pact For iPSC-Derived Allogeneic Cell Therapies
Century Therapeutics Inc (NASDAQ: IPSC) and Bristol Myers Squibb Co (NYSE: BMY) have announced a research collaboration and license agreement for up to... 
Via Benzinga
Century Therapeutics and Bristol Myers Squibb Enter into a Strategic Collaboration to Develop iPSC-derived Allogeneic Cell Therapies
From Bristol Myers Squibb
Via Business Wire
< Previous 1 2
...
28 29 30 31 32 33 34 35 36
...
46 47 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.